02/14/2025
5:53 PM | Fowler John Franklin (Reporting)
Kezar Life Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
9:42 AM | Avidity Partners Management LP (Filed by)
Kezar Life Sciences (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
11:15 PM | Kezar Life Sciences (Filer)
| Form EFFECT | |
01/16/2025
5:33 PM | Kezar Life Sciences (Subject)
Morningside Venture Investments Ltd (Filed by)
| Form SCHEDULE 13D/A | |
01/13/2025
3:15 PM | Kezar Life Sciences (Issuer)
Kirk Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:15 PM | Belsky Marc (Reporting)
Kezar Life Sciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:15 PM | Kezar Life Sciences (Issuer)
Schiller Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:01 AM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
3:45 PM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
11:24 AM | BARCLAYS PLC (Filed by)
Kezar Life Sciences (Subject)
| Form SCHEDULE 13G/A | |
10/29/2024
4:05 PM | Kezar Life Sciences (Filer)
| Form 8-A12B/A | |
Get the Latest News and Ratings for KZR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kezar Life Sciences and its competitors with MarketBeat's FREE daily newsletter. |
10/28/2024
3:06 PM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
8:22 AM | Kezar Life Sciences (Filer)
| Form 8-A12B | |
10/17/2024
7:47 AM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
7:42 AM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
3:20 PM | Kezar Life Sciences (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13D | |
10/04/2024
4:05 PM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:36 AM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
4:41 PM | Kezar Life Sciences (Issuer)
Schiller Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Kezar Life Sciences (Subject)
| Form SC 13G/A | |
06/04/2024
3:30 PM | Kezar Life Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:08 PM | Kezar Life Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:12 PM | Kezar Life Sciences (Filer)
| Form ARS | |
04/16/2024
3:18 PM | Kezar Life Sciences (Filer)
| Form PRE 14A | |
03/14/2024
3:33 PM | Kezar Life Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
